Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Slimbiotics

Slimbiotics is a proprietary consortium of biotic strains targeting weight management company.
2018
Vienna, Wien, Austria
  • Consumer Healthcare
  • Nutraceuticals (e.g. Supplements)
  • Probiotics

Innovation

Industry Problem

Weight-management supplements often lack plant-derived, microbiome-focused ingredients supported by controlled human studies.

R&D Focus

Plant-derived probiotics, synbiotics and postbiotics for weight and metabolic health.

Innovative Solution

The company develops selected Limosilactobacillus fermentum strains, plant substrates and postbiotic preparations intended to influence body fat and metabolic markers.

Solution Effectiveness

A randomized double-blind controlled study evaluated a three-strain synbiotic in people with abdominal overweight, and additional registered trials assessed probiotic and K8-Lb1 postbiotic formulas.

About

Slimbiotics GmbH was founded by Austrian entrepreneurs Helmut Essl and Alexander Schütz with the goal of developing plant-derived, clinically-backed biotics and making them available to consumers looking to maintain a healthy weight and overall metabolic wellbeing. Previous to Slimbiotics, Essl was the founder and CEO of HSO Health Care GmbH, a company offering the branded probiotic solution, Astarte, targeting women’s urogenital health. Astarte was acquired by Chr. Hansen in 2020.

Products

Product

SlimBiotics probiotic, synbiotic and K8-Lb1 postbiotic weight-management formulas.

Star Product

L. fermentum K8-Lb1 postbiotic, the company’s latest clinically studied plant-based weight-management ingredient.

Demo Product or Complete Product?

Clinical-validation and B2B ingredient-development stage.

Something missing or incorrect on this page? Help us enrich this information